News and Trends 9 Jan 2023
Rani Therapeutics provides pipeline update
Rani Therapeutics Holdings, Inc. has completed a pre-investigational new drug (IND) meeting with the U.S. Food and Drug Administration (FDA)…
Clinical trial
- Latest Posts
News and Trends 9 Jan 2023
Alentis reports positive results from fibrosis study
Alentis Therapeutics has announced positive results from a single ascending dose phase 1 study of its lead program, ALE.F02, currently…
News and Trends 6 Jan 2023
Transgene approved for IV oncolytic virus trial
Transgene has received clinical trial application (CTA) approval from the French National Agency for the Safety of Medicines and Health…
News and Trends 4 Jan 2023
Actimed Therapeutics raises £10M for cancer cachexia treatment
Actimed Therapeutics Ltd has completed its second and final £5 million ($6 million) tranche of seed financing. The round was…
ADVERTISEMENT
News and Trends 3 Jan 2023
Janssen looks for talquetamab marketing approval
The Janssen Pharmaceutical Companies of Johnson & Johnson has submitted a marketing authorisation application (MAA) to the European Medicines Agency…
News and Trends 3 Jan 2023
Legend Biotech new drug application approved in China
Legend Biotech Corporation has announced that China’s National Medical Products Administration (NMPA) has formally accepted its new drug application (NDA)…
News and Trends 3 Jan 2023
Newron announces interim results from treatment-resistant schizophrenia trial
Newron Pharmaceuticals S.p.A. has announced what it says are “very compelling new results” from the first 100 enrolled patients to…
News and Trends 3 Jan 2023
Sensorion announces first patient enrolled in cisplatin-induced ototoxicity trial
Sensorion has announced that the first patient has been enrolled in its phase 2a proof of concept clinical trial of…
News and Trends 22 Dec 2022
First CAR-T technology trial for patients with T-cell leukemia subtype authorized
The Spanish Agency of Medicines and Medical Products (AEMPS) has approved the CARxALL clinical trial led by the company OneChain…
News and Trends 22 Dec 2022
Positive Dupixent eosinophilic esophagitis phase 3 results
The New England Journal of Medicine has published results from a positive phase 3 trial showing adults and adolescents treated…
News and Trends 21 Dec 2022
Watch: Mauritius – clinical trials and emerging biotech hub
The Economic Development Board (EDB) in Mauritius commenced its operations as a statutory body in 2018 following the merger between…
News and Trends 21 Dec 2022
Pfizer diabetes and obesity study triggers Sosei Heptares windfall
Sosei Group Corporation has been notified by Pfizer that the first subject in a phase 2 clinical trial has been…
News and Trends 20 Dec 2022
Verona Pharma drug meets COPD phase 3 trial endpoints
Verona Pharma plc has announced positive results of its phase 3 ENHANCE-1 trial evaluating nebulized ensifentrine for the maintenance treatment…
Sponsored by IRBM
20 Dec 2022Diving deep into science: How the life science industry relies on CRO’s drug hunter skills
Over the years, CROs have evolved from a transactional ‘pair of hands’ to organizations that are true partners in their…
News and Trends 19 Dec 2022
UroGen completes bladder cancer phase 3 trial enrollment
UroGen Pharma Ltd. says its phase 3 ENVISION study of investigational agent UGN-102 (mitomycin) for intravesical solution in development for…
News and Trends 19 Dec 2022
SoftOx receives chronic wound study report
Norwegian company SoftOx Solutions AS says it has received the final report and analysis of its phase 1 study evaluating…
ADVERTISEMENT
News and Trends 16 Dec 2022
Astellas gastric cancer drug meets phase 3 primary endpoint
Astellas Pharma Inc. has announced positive topline results from the phase 3 GLOW clinical trial evaluating the efficacy and safety…
News and Trends 14 Dec 2022
NMD Pharma cleared for spinal muscular atrophy trial
NMD Pharma A/S has received clearance for its investigational new drug (IND) application from the US Food and Drug Administration…
News and Trends 14 Dec 2022
ImaginAb launches trial to study neoadjuvant immunotherapy
ImaginAb Inc., in collaboration with Memorial Sloan Kettering Cancer Center (MSK) and Melanoma Research Alliance (MRA), has launched an investigator-initiated…
News and Trends 14 Dec 2022
Asieris doses first patient in bladder cancer diagnostic trial
Asieris Pharmaceuticals has announced that Hexvix, a drug used for bladder cancer diagnosis, completed dosing for the first patient in…
